Drugs Approved for Head and Neck Cancer

This page lists cancer drugs approved by the Food and Drug Administration (FDA) for cancer that arises in the head or neck region (in the nasal cavity, sinuses, lips, mouth, salivary glands, throat, or larynx [voice box]). The list includes generic names and brand names. The drug names link to NCI’s Cancer Drug Information summaries. There may be drugs used in head and neck cancer that are not listed here.

Drugs Approved for Head and Neck Cancer

Bleomycin Sulfate
Cetuximab
Docetaxel
Erbitux (Cetuximab)
Hydrea (Hydroxyurea)
Hydroxyurea
Keytruda (Pembrolizumab)
Loqtorzi (Toripalimab-tpzi)
Methotrexate Sodium
Nivolumab
Nivolumab and Hyaluronidase-nvhy
Opdivo (Nivolumab)
Opdivo Qvantig (Nivolumab and Hyaluronidase-nvhy)
Pembrolizumab
Penpulimab-kcqx
Taxotere (Docetaxel)
Toripalimab-tpzi

Drug Combinations Used in Head and Neck Cancer

CARBOPLATIN-TAXOL
TPF